Skip to content
SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%
Market News

Novartis’s Latest Trial Setback Sinks Stock

Business - Latest - Google News · September 8, 2026

Novartis’s Latest Trial Setback Sinks Stock  WSJCholesterol drug setback casts doubt over multibillion-dollar race  CNBCNovartis shares sink on second pipeline setback this week  ReutersAnother Heart Drug Fails, Shocking Cardiologists  The New York TimesDyne Therapeutics stock faces pressure after rival drug fails trial By Investing.com  Investing.com India

View original source →

More News

Dimon Backs Tata Sons Chief, Warns Rift Could Hit Investment
Gold holds near two-month high as equities slip, oil rallies – Kitco PM Report
Microsoft confirms GitHub is down worldwide
Why This Indian Founder Left America For Europe: 'I Fell In Love'